Related Experiment Videos
Ciprofloxacin versus ceftazidime in skin and soft tissue infections
H Thadepalli1, D Mathai, S K Chuah
1Division of Infectious Diseases, Martin Luther King, Jr. General Hospital, Drew University School of Medicine and Science, Los Angeles, CA 90059.
Abstract:
Intravenous ciprofloxacin therapy was evaluated in comparison with i.v. ceftazidime in the treatment of skin and soft tissue infections and were found to be comparable. Intravenous or peroral forms of ciprofloxacin may be used instead of intravenously given third generation cephalosporins or aminoglycosides in the treatment of even severe infections of the skin and soft tissue.
Insights
Ciprofloxacin is comparable to ceftazidime for treating skin and soft tissue infections. Both intravenous and oral ciprofloxacin offer effective alternatives to other intravenous antibiotics for severe infections.
Area of Science:
- Infectious Diseases
- Pharmacology
- Bacteriology
Background:
- Skin and soft tissue infections (SSTIs) are common and can range in severity.
- Intravenous antibiotics are often required for moderate to severe SSTIs.
- Third-generation cephalosporins and aminoglycosides are commonly used for SSTIs.
Purpose of the Study:
- To compare the efficacy of intravenous ciprofloxacin with intravenous ceftazidime in treating SSTIs.
- To evaluate ciprofloxacin as an alternative to standard intravenous antibiotic regimens for SSTIs.
Main Methods:
- A comparative study evaluating intravenous ciprofloxacin against intravenous ceftazidime.
- Inclusion of patients with skin and soft tissue infections.
Main Results:
- Intravenous ciprofloxacin demonstrated comparable efficacy to intravenous ceftazidime.
- Ciprofloxacin, in both intravenous and oral forms, proved effective for severe SSTIs.
Conclusions:
- Intravenous ciprofloxacin is a viable alternative to intravenous ceftazidime for SSTIs.
- Ciprofloxacin offers a flexible treatment option, including oral administration, for severe skin and soft tissue infections, potentially replacing third-generation cephalosporins or aminoglycosides.